heart failure glp-1 Agonist Therapy for Advanced With Reduced Ejection Fraction Early trials of GLP-1 based

95% CI, 1.22-2.43

The recommended dose is 5 mcg twice daily initially, which may be increased to 10 mcg twice daily after one month based on clinical response and tolerability

JAMA, 332 (7), 571584

Reverse-phase evaporation method This is an alternative approach for the hydration method utilizing thin films, instead of employing a water-oil emulsion formation process

Key Developments On March 6, 2026 , Merck KGaA expanded its specialty chemicals and life science portfolio by enhancing production capabilities for high-purity glutathione used in pharmaceutical and nutraceutical applications

Unlike oral supplements, nebulized therapy delivers nutrients right where theyre needed most allowing for faster absorption and targeted cellular benefits